Integral Health Asset Management, LLC
Q2 2025 13F Holdings
- Locationnew york, NY
- Num holdings
72
- Value ($000)
$1,092,288
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001773206
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
---|---|---|---|---|---|---|---|
INSM INSMED INC | COM PAR $.01 | 457669307 | $161.02M | 15 % | 1,600,000 | ||
BSX BOSTON SCIENTIFIC CORP | COM | 101137107 | $59.08M | 5 % | 550,000 | ||
THC TENET HEALTHCARE CORP | COM NEW | 88033G407 | $48.40M | 4 % | 275,000 | ||
EHC ENCOMPASS HEALTH CORP | COM | 29261A100 | $39.24M | 4 % | 320,000 | ||
MLYS MINERALYS THERAPEUTICS INC | COM | 603170101 | $36.53M | 3 % | 2,700,000 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $33.04M | 3 % | 1,000,000 | ||
BTSG BRIGHTSPRING HEALTH SVCS INC | COM | 10950A106 | $29.49M | 3 % | 1,250,000 | ||
VERA VERA THERAPEUTICS INC | CL A | 92337R101 | $27.09M | 3 % | 1,150,000 | ||
DGX QUEST DIAGNOSTICS INC | COM | 74834L100 | $26.94M | 3 % | 150,000 | ||
REGN REGENERON PHARMACEUTICALS | COM | 75886F107 | $26.25M | 2 % | 50,000 |
Rows Per Page
10
- 10
- 50
- 100